Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Polyvinylpyrrolidone(PVP)-modified
LFLX
-Tb3+ nanoparticles were prepared by microwave radiation method. The obtained products were characterized by means of
SEM
, FTIR and fluorescence spectra. The surface-modified
LFLX
-Tb3+ nanoparticles showed a narrow size distribution and enhanced luminescence property compared with that of the unmodified ones. These results were attibuted to the surface passivation of the
LFLX
-Tb3+ nanoparticles by the PVP molecules. It is confirmed that the addition dosage of PVP is an important factor in the preparation of the
LFLX
-Tb3+ nanoparticles. The reasons for luminescence enhancement were discussed.
...
PMID:[Preparation of lomefloxacin-Tb3+ nanoparticles modified by PVP via microwave-assistance and its properties of fluorescence]. 1776 83